Objective: This study aimed to compare haematological, biochemical, and serological parameters in haemodialysis (HD) patients with Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD) in order to identify distinctive laboratory patterns with potential clinical relevance.
Methodology: This cross-sectional study included 77 patients undergoing HD at a tertiary centre: 45 with AKI and 32 with CKD. Demographic characteristics and a broad panel of laboratory parameters encompassing haematological indices, inflammatory markers, liver and cholestatic enzymes, electrolyte and mineral metabolism, iron parameters, and serological markers were analysed. Group comparisons were performed using appropriate statistical tests. Receiver Operating Characteristic (ROC) analyses were conducted for Helicobacter pylori (HP) IgA and IgG.
Results: Patients with AKI were significantly older than those with CKD (p=0.001), while sex distribution was similar. Compared with CKD patients, the AKI group demonstrated a laboratory profile characterised by higher inflammatory and tissue injury markers, including white blood cell count, neutrophils, C-reactive protein, lactate dehydrogenase, and D-dimer (all p<0.05). In contrast, CKD patients exhibited higher levels of creatinine, parathyroid hormone, ferritin, iron indices, and alkaline phosphatase, consistent with chronic kidney disease–related metabolic alterations (all p<0.05). No significant differences were observed in HP IgA or IgG levels, and ROC analyses showed no discriminative value for distinguishing AKI from CKD.
Conclusion: HD patients with AKI and CKD exhibit distinct multisystem laboratory patterns reflecting acute inflammatory activity versus chronic metabolic adaptation. Recognising these differences may improve contextual interpretation of laboratory findings and support more individualised clinical decision-making in the HD setting.
Acute kidney injury Chronic kidney disease Haematological and biochemical parameters Helicobacter pylori Haemodialysis Inflammation markers
This study was approved by the Giresun Training and Research Hospital Clinical Research Ethics Committee (Committee Name: Giresun Eğitim ve Araştırma Hastanesi Klinik Araştırmalar Etik Kurulu; Date: 04.12.2023; Decision No: 04.12.2023/27). All procedures were conducted in accordance with the ethical standards of the institutional research committee and with the principles of the Declaration of Helsinki (revised 2024).
| Primary Language | English |
|---|---|
| Subjects | Internal Diseases |
| Journal Section | Research Article |
| Authors | |
| Submission Date | December 11, 2025 |
| Acceptance Date | January 22, 2026 |
| Early Pub Date | January 23, 2026 |
| Publication Date | January 23, 2026 |
| Published in Issue | Year 2026 Issue: Advanced Online Publication |
CJM welcomes submissions from all fields of medicine, with particular interest in disciplines such as Orthopedics, Pediatrics, Internal Medicine, General Surgery, Emergency Medicine, Cardiology, Neurology, Obstetrics and Gynecology, Anesthesiology and Reanimation, Radiology, Physical Medicine and Rehabilitation, Family Medicine, Infectious Diseases, Dermatology, Psychiatry, Chest Diseases, Ophthalmology, Pathology, Microbiology, Biochemistry, and Physiology, as well as other related clinical and basic science specialties. The journal also welcomes high-quality contributions in Public Health, Clinical Epidemiology, Biomedical Sciences, Medical Education, Health Sciences, Dentistry, and multidisciplinary research relevant to healthcare.
CJM prioritizes manuscripts with robust methodology, clear clinical relevance, and innovative scientific perspectives. The journal publishes a broad range of scholarly work, including original research articles, clinical studies, systematic reviews, and case reports.
Through its commitment to a rigorous peer-review system and adherence to internationally recognized ethical principles, Cerasus Journal of Medicine aims to uphold high scientific standards and to support the dissemination of reliable medical knowledge within the global research community.
General information
Institutional review board/ethics committee approval (IRB)
Download the WORD file for the sample file.
Table-1. Limitations for each manuscript type
| Type of Manuscript | Word Limit* | Abstract Word Limit | Keyword Limit | Reference Limit | Table Limit | Figure Limit |
| Original Articles | 5000 | 350 | 6 | 50 | 6 | 6 |
| Review Articles | 7000 | 350 | 6 | 50 | 6 | 6 |
| Case Reports | 2500 | 300 | 6 | 20 | 3 | 6 |
| Letter to the Editor | 1000 | No abstract | 3 | 5 | 2 | 2 |
| Pictorial Essay | 1500 | 100 | 3 | 15 | No Tables | 15 |
* For "Word Limit", abstracts and references are excluded.
Title: A title that accurately describes the article and is concise is preferred. Only the first letter of each word in the title should be capitalized.
Authors: Author names must be clearly written. Abbreviations must not be used. Each author's ORCID ID number must be written. Each author's institution must be listed in the order Department, Faculty, University, City, and Country. If the institution is present, its ROR ID must be written after the address.
Abstract: The word limit in the abstracts should be written according to the numbers in the table above, and it should include the following subheadings: Objective, Methods, Results, Conclusion.
Keywords: Keywords are required for indexing and abstracting services. The keywords that will best express the work should be determined.
Main text: The main text of an original article should be divided into INTRODUCTION, METHODS, RESULTS, DISCUSSION, and CONCLUSION sections. The case report should include an abstract, introduction, case report, discussion, and references. Abbreviations must be defined following their first use in the Abstract as well as in the main text and in the figures and tables. Only commonly accepted abbreviations should be used. Drug and chemical names should be stated using generic or standard chemical nomenclature. Units of measurement should conform to the International System (SI); however, clinical data may be presented in conventional units where deemed more appropriate.
Headings and subheadings:
Footnotes:
Tables
Figures
Article Information Form
The article information form should be written after the text, before the references. Explain the following headings in detail.
Acknowledgments:
Financial Disclosure:
Conflicts of interest:
Ethical Declaration:
Artificial Intelligence Statement:
Author Contributions: (The statement "Authors' contribution to the article is equal" is not accepted.) To be considered as an author of an article, a writer must have contributed to at least 3 of the following. If any of the following headings are not relevant to your work, please mark them as "None".
Conceptualization: F.A., S.A.;
Methodology: F.A., S.A.;
Software: T.A.;
Validation: F.A., T.A.;
Formal analysis: S.A.;
Investigation: F.A.;
Resources: T.A.;
Data curation: F.A.;
Writing – original draft: S.A.;
Writing – review & editing: F.A.;
Visualization: S.A.;
Supervision: None;
Project administration: F.A., S.A.;
Funding acquisition: None.;
Reference Style and Format
The reference styles for different types of publications are presented in the following examples:
Morehouse R, Macqueen G, Kennedy SH. Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction. J Affect Disord. 2011;132(Suppl 1):S14-20. doi:10.1016/j.jad.2011.03.047.
For the published article from the journal that is not placed and is not abbreviated in Medline:
Articles in press
Article with published erratum
Volume with supplement
Issue with supplement
Volume with part
Issue with part
Issue with no volume
No volume or issue
Journal article on the Internet
For books and other monographs
Personal author(s)
Author(s) and editor(s)
Organization(s) as author
Editor(s), compiler(s) as author
Translated book
Chapter in a book
Conference proceedings
Dissertation (Thesis)
Poster(s)
Patent
Homepage/Website
Proofreading
After the Cerasus Journal of Medicine has prepared the layout of the article, it is sent to all authors for proofreading. All authors must view the pre-publication version of the article and approve its publication.
Multicenter clinical trials
The Cerasus Journal of Medicine welcomes submissions of manuscripts reporting the results of multicentre clinical trials. These manuscripts may be submitted with authorship in one of the following styles:
• The name of a study group only (collective authorship).
• The names of no more than five individuals, along with the name of a study group.
In each case, one individual must serve as the corresponding author. The names of all individuals involved in preparing the manuscript should be listed under the 'Writing Committee' heading, after the 'Acknowledgements' section. This should be followed by a list of investigators from each institution under the heading 'Study Group Investigators'. All authors and Writing Committee members must sign the Copyright Agreement and Author Acknowledgement Form.
Responsibility for content
Disclaimer
Although all advertising material in the Cerasus Journal of Medicine is expected to adhere to ethical standards, its inclusion in this publication does not imply endorsement by the Cerasus Journal of Medicine of the quality or value of any product, nor of any claims made by its manufacturer.
• Cerasus Journal of Medicine does not charge any fees for article submission, peer review, editorial processing, page layout, or publication (including page or color charges).
• Cerasus Journal of Medicine does not pay any fees or honoraria to authors, reviewers, editors, or editorial board members.
• All articles are free to read and download.
• Cerasus Journal of Medicine is an open-access journal and does not require any subscription fees.
• Cerasus Journal of Medicine is a signatory to the Budapest Open Access Initiative (BOAI) and adheres to the Open Access principles set out in this initiative.
• All articles are preserved via the LOCKSS (Lots Of Copies Keep Stuff Safe) system through TÜBİTAK ULAKBİM DergiPark.
• In line with its publication policy, the journal does not accept announcements, advertisements, sponsorships, or similar content.
• The journal does not offer a reprint service for professional-quality reproductions of articles.
• All expenses of the Cerasus Journal of Medicine are covered by the publisher.